Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Combretum platypterum extract is a botanical extract derived from the roots, leaves, flowers, or twigs of the scandent shrub *Combretum platypterum* (family Combretaceae), which is native to tropical Africa. Traditionally used in folk medicine to treat malaria, fever, pain, and inflammatory conditions, the extract has been investigated for its antiplasmodial, analgesic, and anti-inflammatory properties. Phytochemical analyses of the extract have identified bioactive constituents such as alkaloids, saponins, tannins, flavonoids, and specific compounds like 3,3',4-tri-O-methylellagic acid, which exhibit significant in vitro activity against both chloroquine-sensitive and chloroquine-resistant strains of *Plasmodium falciparum*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Combretum platypterum extract.